ArticleFrontiers in molecular biosciences2022

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.

Yuliang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.